View Older Stories View More Recent Stories

Nov 13, 2015 08:46AM Alcobra Ltd. (ADHD) Prices 6.18M Ordinary Stock Offering at $6.50/Share

Nov 13, 2015 08:45AM Alcobra Ltd. Prices Public Offering of Ordinary Shares

Nov 13, 2015 08:45AM Alcobra Ltd. Prices Public Offering of Ordinary Shares

Nov 13, 2015 07:47AM RAVE Restaurant Group (RAVE) Reports Rough Same Store Comps; Roth Capital Cuts Price Target to $14

Nov 13, 2015 06:47AM Roth Capital Starts Outerwall Inc. (OUTR) at Buy

Nov 13, 2015 06:34AM Roth Capital Starts Glu Mobile (GLUU) at Buy

Nov 13, 2015 06:33AM Roth Capital Downgrades Digital Ally (DGLY) to Neutral Following Disappointing Q3

Nov 12, 2015 08:47AM Roth Capital Raises Price Target on Future Fuel (FF) Following 3Q Revenue Beat

Nov 12, 2015 07:34AM FX Hits Middleby Corp's (MIDD) Net Sales; Roth Capital Cuts Price Target to $130

Nov 12, 2015 07:24AM Good Execution by Horizon Global (HZN) Drives Revenue Growth; Roth Capital Raises price Target to $13

Nov 12, 2015 07:00AM Telesta Therapeutics Publishes its Q1, 2016 Financial Statements and Provides Corporate Updates

Nov 11, 2015 02:11PM APTO-253 Remains in Focus for Aptose Biosciences (APTO); Roth Affirms at 'Buy'

Nov 11, 2015 07:56AM Zosano Pharma (ZSAN) Reported 3Q EPS Miss; Roth Capital Reiterates Buy

Nov 11, 2015 07:47AM 3Q EPS Miss Driven by Decline in Revenue; Roth Capital Reiterates Buy on Iconix Brand Group (ICON)

Nov 11, 2015 07:39AM Hydrogenics (HYGS) Reports Mixed 3Q Results; Roth Capital Reiterates Buy

Nov 11, 2015 07:30AM Roth Capital Reiterates Buy on Canadian Solar (CSIQ) Following 3Q

Nov 11, 2015 07:19AM Hackett Group, Inc. (HCKT) Shows Strength in North America; Roth Capital Raises Price Target to $18

Nov 11, 2015 06:49AM Canadian Solar (CSIQ) Capacity Expansion Continues Accelerating; Roth Affirms at 'Buy'

Nov 10, 2015 09:18AM Roth Trims PT on Galena (GALE) Following Q3 Results, Plans to Spin Commercial Assets

Nov 10, 2015 07:39AM Roth Capital Cuts Price Target on Exar Corp. (EXAR) Following In-Line 2Q Results

Nov 9, 2015 02:54PM Curis (CRIS) Outpaces in Q3; Roth Affirms 'Buy' Rating Ahead of ASH

Nov 9, 2015 02:20PM TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference

Nov 9, 2015 09:00AM ROTH Capital Partners Honored by Global M&A Network

Nov 9, 2015 08:40AM Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 3Q15

Nov 9, 2015 07:32AM Cytokinetics (CYTK) and Amgen Inc. (AMGN) Announce COSMIC-HF Data; Roth Capital Raises Price Target to $22

Nov 9, 2015 07:00AM RedHill Biopharma Reports Results for the Third Quarter of 2015

Nov 6, 2015 09:41AM First Data from Rexahn's (RNN) Archexin Phase 2a Release; Appears Right on Track - Roth

Nov 6, 2015 09:13AM Vascular Biogenics Ltd. Announces Closing of $15 Million Underwritten Offering of Ordinary Shares and Warrants

Nov 6, 2015 09:05AM Pixelworks to Participate at ROTH Technology Corporate Access Day on November 18

Nov 6, 2015 09:00AM Adesto Technologies to Participate at ROTH New York Technology Corporate Access Day on November 18

Nov 6, 2015 08:37AM Skullcandy's (SKUL) Higher-Than-Expected Gross Margin Offset Low Revenue; Roth Capital Reiterates Buy

Nov 6, 2015 08:17AM Sarepta (SRPT) Conditional-Approval Thesis Unchanged, Roth Capital Says

Nov 6, 2015 08:11AM Roth Capital Starts Dimension Therapeutics (DMTX) at Buy

Nov 6, 2015 08:10AM Roth Capital Downgrades Constant Contact (CTCT) to Sell Amid Pending Takeover

Nov 5, 2015 04:30PM Intec Pharma Reports Results for the Third Quarter of 2015

Nov 5, 2015 01:27PM bluebird bio (BLUE) LentiGlobin is Here To Stay, Roth Capital Says; PT Cut to $165

Nov 5, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 11/5: (VRX) (CAB) (QCOM) (BLRX) (RNWK)

Nov 5, 2015 11:51AM BioLineRx's (BLRX) Latest BL-8040 Phase 2 Data in r/r AML is 'Intriguing' - Roth Capital

Nov 5, 2015 09:32AM Pre-Open Stock Movers 11/05: (AWAY) (SD) (FB) Higher; (XENT) (LCI) (BLUE) Lower (more...)

Nov 5, 2015 08:17AM Roth Capital Downgrades Energy Focus (EFOI) to Neutral

Nov 5, 2015 07:43AM Roth Capital Downgrades Sapiens International Corp. NV (SPNS) to Neutral

Nov 5, 2015 07:24AM Roth Capital Upgrades Cogentix Medical (CGNT) to Buy

Nov 4, 2015 11:00AM Gerhard Erdelji Joins HomeStreet to Lead Investor Relations

Nov 4, 2015 09:48AM Roth Capital Raises Price Target on MaxLinear (MXL) Following 3Q Results

Nov 4, 2015 09:38AM Same-Store Sales Remain Strong; Roth Capital Remains Neutral on Denny's Corp (DENN)

Nov 4, 2015 09:00AM ROTH Capital Partners to Host Technology Corporate Access Day in New York City, NY on November 18th, 2015

Nov 4, 2015 08:42AM Top Image Systems to Participate in the ROTH Technology Corporate Access Day in New York

Nov 4, 2015 08:18AM Better Than Anticipated Cash Costs Drive EPS Beat for Coeur Mining (CDE); Roth Capital Reiterates Buy

Nov 4, 2015 08:13AM Non-Core Brands Downside Contribute to ANI Pharma's (ANIP) Revenue Miss; Roth Capital Reiterates Buy

Nov 4, 2015 06:43AM MeetMe (MEET) PT Bumped to $4.25 at Roth Capital Post Q3

View More Recent Stories View Older Stories